Share on:
Medical Metrics, a provider of imaging core lab services for orthopedic clinical trials, has been selected by five leading orthopedic device manufacturers to support multiple cross-sectional post-market FDA surveillance studies of metal-on-metal (MoM) hip implants. MMI will independently evaluate radiographs and MRI to assess long-term outcomes in patients implanted with MoM hips. Over 2,000 subjects will be evaluated at one to 10 years post-implantation.
The goal of these studies is to comply with the FDA’s 522 order requiring manufacturers of MoM hip implants to conduct clinical surveillance of the effect of device wear in implanted patients. (Source: Medical Metrics, Inc.)
RELATED ARTICLES
Janco Medical to Focus on Packaging and Cleanroom Manufacturing
Apr 10 2024 , Julie A. Vetalice
Evonik Grows Capacity for Customized RESOMER Powder Biomaterials
Apr 10 2024 , Julie A. Vetalice
Exploring Why Automation Leads to Improved Medical Device Manufacturing
Apr 09 2024 , Lowell